John R. Falck mainly investigates Biochemistry, Arachidonic acid, Internal medicine, Endocrinology and Cytochrome P450. His Biochemistry research is multidisciplinary, incorporating elements of Molecular biology and Stereochemistry. The various areas that John R. Falck examines in his Arachidonic acid study include Metabolite, Microsome and Metabolism.
His work on Endocrinology is being expanded to include thematically relevant topics such as Cyclooxygenase. His Epoxygenase study incorporates themes from Epoxide hydrolase 2 and Pharmacology. His Kidney research is multidisciplinary, relying on both Vasoconstriction and Vascular smooth muscle.
His primary areas of study are Internal medicine, Endocrinology, Biochemistry, Arachidonic acid and Stereochemistry. His Internal medicine study frequently draws connections to other fields, such as 20-Hydroxyeicosatetraenoic acid. His Endocrinology study focuses mostly on Vasodilation, Angiotensin II, Endothelium, Vascular smooth muscle and Nitric oxide.
Biochemistry is closely attributed to Pharmacology in his research. He interconnects Metabolite, Cytochrome and Cytochrome P450, Metabolism in the investigation of issues within Arachidonic acid. John R. Falck focuses mostly in the field of Stereochemistry, narrowing it down to matters related to Organic chemistry and, in some cases, Medicinal chemistry.
John R. Falck focuses on Internal medicine, Endocrinology, Epoxyeicosatrienoic acid, Pharmacology and Blood pressure. His study brings together the fields of Arachidonic acid and Internal medicine. The study incorporates disciplines such as Vasoconstriction, Inflammation and Endothelial stem cell in addition to Arachidonic acid.
Kidney, Angiotensin II, Vasodilation, Epoxygenase and Cytochrome P450 are the core of his Endocrinology study. His Cytochrome P450 study is concerned with the field of Biochemistry as a whole. His research in Epoxyeicosatrienoic acid intersects with topics in Heart failure, Kidney disease, Radiation Nephropathy, Receptor and Myocardial infarction.
John R. Falck mostly deals with Endocrinology, Internal medicine, Epoxyeicosatrienoic acid, Cytochrome P450 and Kidney. His studies deal with areas such as Wnt signaling pathway, SIRT3, Downregulation and upregulation and 20-Hydroxyeicosatetraenoic acid as well as Internal medicine. The Epoxyeicosatrienoic acid study combines topics in areas such as Endothelial stem cell, Agonist, Receptor, Epoxygenase and Vasodilation.
Epoxygenase is a subfield of Arachidonic acid that John R. Falck explores. As part of one scientific family, he deals mainly with the area of Cytochrome P450, narrowing it down to issues related to the Epoxide hydrolase 2, and often Cell biology, Inflammation, Tetrazole, Carboxylate and Epoxide. John R. Falck combines subjects such as Oxidative phosphorylation and Biochemistry with his study of Cell biology.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Role of Substrates and Products of PI 3-kinase in Regulating Activation of Rac-Related Guanosine Triphosphatases by Vav
Jaewon Han;Katherine Luby-Phelps;Balaka Das;Xiaodong Shu.
Science (1998)
Cytochrome P450 and arachidonic acid bioactivation: molecular and functional properties of the arachidonate monooxygenase
Jorge H. Capdevila;John R. Falck;Raymond C. Harris.
Journal of Lipid Research (2000)
Lysine propionylation and butyrylation are novel post-translational modifications in histones.
Yue Chen;Robert Sprung;Yi Tang;Haydn Ball.
Molecular & Cellular Proteomics (2007)
High Affinity Binding of Inositol Phosphates and Phosphoinositides to the Pleckstrin Homology Domain of RAC/Protein Kinase B and Their Influence on Kinase Activity*
Matthias Frech;Mirjana Andjelkovic;Evan Ingley;K. Kishta Reddy.
Journal of Biological Chemistry (1997)
MOLECULAR CLONING AND EXPRESSION OF CYP2J2, A HUMAN CYTOCHROME P450 ARACHIDONIC ACID EPOXYGENASE HIGHLY EXPRESSED IN HEART
Shu Wu;Cindy R. Moomaw;Kenneth B. Tomer;John R. Falck.
Journal of Biological Chemistry (1996)
Targeting QseC Signaling and Virulence for Antibiotic Development
David A. Rasko;Cristiano G. Moreira;De Run Li;Nicola C. Reading.
Science (2008)
Human cytochromes P450
Julia A Hasler;Ronald Estabrook;Michael Murray;Irina Pikuleva.
Molecular Aspects of Medicine (1999)
Cytochrome P450 and the arachidonate cascade.
Jorge H. Capdevila;J R Falck;Ronald W. Estabrook.
The FASEB Journal (1992)
Structure-activity analysis of the interaction of curacin A, the potent colchicine site antimitotic agent, with tubulin and effects of analogs on the growth of MCF-7 breast cancer cells.
Pascal Verdier-Pinard;Jing Yu Lai;Hae Dong Yoo;Jurong Yu.
Molecular Pharmacology (1998)
A tagging-via-substrate technology for detection and proteomics of farnesylated proteins
Yoonjung Kho;Sung Chan Kim;Chen Jiang;Deb Barma.
Proceedings of the National Academy of Sciences of the United States of America (2004)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Vanderbilt University
Medical College of Wisconsin
Centre national de la recherche scientifique, CNRS
University of Mississippi Medical Center
Medical College of Wisconsin
National Institutes of Health
Medical College of Wisconsin
University of California, Davis
Soochow University
Medical College of Wisconsin
Johns Hopkins University
Rice University
Hasso Plattner Institute
Istanbul Medipol University
Grenoble Alpes University
Bar-Ilan University
ETH Zurich
INRAE : Institut national de recherche pour l'agriculture, l'alimentation et l'environnement
Heinrich Heine University Düsseldorf
University of Toronto
Cincinnati Children's Hospital Medical Center
University of Iowa
Lomonosov Moscow State University
City, University of London
University Medical Center Groningen
University of Nottingham